| EAV percentage improvement | |||||
---|---|---|---|---|---|---|
VR group | PNF group | |||||
Mean ± SD | p value | Mean ± SD | p value | |||
Handedness | Yes | No | Â | Yes | No | Â |
22.76 ± 20.79 | 30.70 ± 27.47 | 0.694 | 28.17 ± 23.02 | 2.52 ± 64.33 | 0.753 | |
Menopause | Pre | Post | Â | Pre | Post | Â |
10.78 ± 12.66 | 32.17 ± 24.43 | 0.177 | 7.25 ± 68.36 | 26.45 ± 21.31 | 0.949 | |
Stage of lymphedema | Stage I | Stage II | Â | Stage I | Stage II | Â |
31.64 ± 25.15 | 12.24 ± 10.94 | 0.177 | 24.06 ± 49.80 | 18.21 ± 18.97 | 0.189 | |
 | QuickDASH-9 score percentage improvement | |||||
Group A | Group B | |||||
Mean ± SD | p value | Mean ± SD | p value | |||
Handedness | Yes | No | Â | Yes | No | Â |
31.46 ± 9.78 | 36.16 ± 23.20 | 0.779 | 14.95 ± 17.43 | 33.19 ± 23.54 | 0.177 | |
Menopause | Pre | Post | Â | Pre | Post | Â |
37.12 ± 13.81 | 32.39 ± 18.29 | 0.571 | 22.45 ± 18.86 | 18.86 ± 21.38 | 0.851 | |
Stage of lymphedema | Stage I | Stage II | Â | Stage I | Stage II | Â |
33.96 ± 17.98 | 32.83 ± 15.78 | 0.949 | 25.29 ± 18.47 | 13.56 ± 21.51 | 0.336 |